REQUEST A DEMO
Total
USD $0.00
Search more companies

Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Gwo Xi Stem Cell Applied Technology Co., Profile Updated: February 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司) is a company based in Taiwan, China, with its head office in Hsinchu City. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on March 26, 2004. There are currently 51 (2023) people employed by Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司). The latest financial highlights indicate a net sales revenue increase of 18.7% in Q2C2025. Over the same period, its total assets decreased by 11.48%. Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司)’s net profit margin increased by 23.47% in 2025.

Headquarters
8F., No.243, Dong Sec. 1, Guangming 6Th Rd
Hsinchu City; Hsinchu City;

Contact Details: Purchase the Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司) report to view the information.

Website: http://www.gwoxi.com.tw

Basic Information
Total Employees:
Purchase the Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司) report to view the information.
Financial Auditors:
Purchase the Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司) report to view the information.
Incorporation Date:
March 26, 2004
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
2.25%
Purchase this report to view the information.
1.78%
Purchase this report to view the information.
1.68%
Purchase this report to view the information.
1.53%
Purchase this report to view the information.
1.14%
Subsidiaries
啟安國際生醫投資股份有限公司
100%
Company Performance
Financial values in the chart are available after Gwo Xi Stem Cell Applied Technology Co., (国玺干细胞应用技术股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
18.7%
Total Operating Revenue
18.69%
Operating Profit
29.49%
EBITDA
86.68%
Net Profit/Loss for the Period
27.38%
Total Assets
-11.48%
Total Equity
-10.08%
Operating Profit Margin
22.75%
Net Profit Margin
23.47%
Return on Equity (ROE)
1.33%
Debt / Equity
-0.2%
Quick Ratio
-0.41%
Cash Ratio
-0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?